Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
The aim of this double-blind randomized clinical trial is to determine the effects of synbiotic supplement on cardiovascular disease risk factors and bone metabolism markers and depression, in transplanted kidney patients on chronic post-kidney transplant phase diet.This study is a double-blind, randomized controlled clinical trial with two parallel groups. 44 patients will be randomly assigned into synbiotic and control group. Transplanted kidney patients referring to the hospital clinics will be invited to participate. After assessing the entrance criteria, 7 cc blood samples are taken. The food recall is completed. Supplements are given to patients for 10-12 weeks. Serum concentrations of malondialdehyde; high sensitivity c-reactive protein; Soluble intercellular adhesion molecule-1; glucose; pentosidine; carboxy-methyl lysine; osteoprotegerin; Receptor activator of nuclear factor kappa-Β ligand; N-telopeptide; Intact parathyroid hormone; triglyceride; total cholesterol; High-density lipoprotein cholesterol; low-density lipoprotein cholesterol; lipoprotein-a; albumin; calcium; phosphorous; blood nitrogen urea; creatinine; and also systolic blood pressure; diastolic blood pressure; Weight; Body mass index; Waist circumference; Hip circumference; and questionnaires including quality of depression.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| synbiotic | Active Comparator | Patients in the synbiotic group will receive, for 10-12 weeks, Two capsules of synbiotic (Zist Takhmir Company) per day, each containing 500 mg of synbiotic. Patients in this group received a multispecies probiotic product (109 CFU/capsule) and fructo oligosaccharid as prebiotics. |
|
| placebo | Placebo Comparator | Patients in the placebo group will receive Two capsules of placebo containing maltodextrin per day. The placebo powder will comparable in color, texture, and taste to the synbiotics. Supplement packaging will be done by Zist Takhmir Company. |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| synbiotic | Dietary Supplement | Two capsules of synbiotic per day, each containing 500 mg of synbiotic |
|
| Measure | Description | Time Frame |
|---|---|---|
| Lp (a) | Serum concentrations of lipoprotein-a | 10 weeks |
| MDA | Serum concentrations of malondialdehyde | 10 weeks |
| hs-CRP | Serum concentrations of high sensitivity c-reactive protein | 10 weeks |
| sICAM-1 | Serum concentrations of Soluble intercellular adhesion molecule-1 | 10 weeks |
| glucose | serum concentration of fasting glucose | 10 weeks |
| pentosidine | serum concentration of pentosidine | 10 weeks |
| carboxy-methyl lysine | serum concentration of carboxy-methyl lysine | 10 weeks |
| Osteoprotegerin | Serum concentrations of Osteoprotegerin | 10 weeks |
| osteocalcin | Serum concentrations of osteocalcin | 10 weeks |
| Measure | Description | Time Frame |
|---|---|---|
| albumin | Serum concentrations of albumin | 10 weeks |
| calcium | Serum concentrations of calcium | 10 weeks |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
| Name | Role | Phone | Extension | |
|---|---|---|---|---|
| zahra yari, PhD | Contact | +982122357484 | zahrayari_nut@yahoo.com |
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D058616 | Synbiotics |
| ID | Term |
|---|---|
| D056692 | Prebiotics |
| D019587 | Dietary Supplements |
| D005502 | Food |
| D000066888 | Diet, Food, and Nutrition |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| placebo | Other | Two capsules of placebo containing maltodextrin per day |
|
| RANKL | Serum concentrations of Receptor activator of nuclear factor kappa-Β ligand | 10 weeks |
| Systolic blood pressure | Systolic blood pressure (mmHg) | 10 weeks |
| Diastolic blood pressure | Diastolic blood pressure (mmHg) | 10 weeks |
| N-telopeptide | Serum concentrations of N-telopeptide | 10 weeks |
| triglyceride | Serum concentrations of triglyceride | 10 weeks |
| Total cholesterol | Serum concentrations of total cholesterol | 10 weeks |
| HDL-C | Serum concentrations of High-density lipoprotein cholesterol | 10 weeks |
| LDL-C | Serum concentrations of low-density lipoprotein cholesterol | 10 weeks |
| the Beck depression test | Score of the Beck depression test | 10 weeks |
| The Depression Anxiety Stress Scale | Score of Depression Anxiety Stress Scale-(DASS)42 | 10 weeks |
| Weight | body Weight in kilograms | 10 weeks |
| Waist circumference | Waist circumference | 10 weeks |
| Hip circumference | Hip circumference | 10 weeks |
| phosphorous | Serum concentrations of phosphorous | 10 weeks |
| iPTH | Serum concentrations of Intact parathyroid hormone | 10 weeks |
| D010829 |
| Physiological Phenomena |
| D019936 | Probiotics |
| D019602 | Food and Beverages |